The stock of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is a huge mover today! The stock increased 8.05% or $0.33 on November 23, hitting $4.43. About 329,754 shares traded hands or 29.60% up from the average. Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has declined 32.67% since April 22, 2016 and is downtrending. It has underperformed by 38.08% the S&P500.
The move comes after 5 months positive chart setup for the $89.71M company. It was reported on Nov, 24 by Barchart.com. We have $4.61 PT which if reached, will make NASDAQ:EKSO worth $3.59M more.
Analysts await Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) to report earnings on March, 13. They expect $-0.39 earnings per share, up 38.10% or $0.24 from last year’s $-0.63 per share. After $-0.51 actual earnings per share reported by Ekso Bionics Holdings, Inc. for the previous quarter, Wall Street now forecasts -23.53% EPS growth.
According to Zacks Investment Research, “Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company’s operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.”
Another recent and important Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) news was published by Marketwatch.com which published an article titled: “Ekso initiated at buy at B. Riley” on January 19, 2014.
EKSO Company Profile
Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., incorporated on January 30, 2012, designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Firm operates through two divisions: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and makes exoskeletons for applications in the medical and military markets. The Company’s exoskeleton systems are worn over the user’s clothing. These systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.